• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Jazz Pharma Plc (NQ: JAZZ )

    106.23 -0.50 (-0.47%)
    Streaming Delayed Price Updated: 12:21 PM EDT, Jul 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 131,402
    Open 106.73
    Bid (Size) 106.15 (4)
    Ask (Size) 106.34 (2)
    Prev. Close 106.73
    Today's Range 106.22 - 108.52
    52wk Range 103.01 - 146.70
    Shares Outstanding 62,311,104
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    7 Biotech Stocks to Boost Your Portfolio to Peak Health
    With biotech stocks commanding a permanently relevant narrative, you can’t afford to ignore these highly endorsed ideas. 
    Via InvestorPlace
    3 Cannabis Stocks That Could Make Your Grandchildren Rich
    These cannabis stocks offer long-term growth potential anchored by solid operational models and diversified revenue streams today. 
    Via InvestorPlace
    Topics Cannabis
    Exposures Cannabis

    Performance

    YTD
    -16.31%
    -16.31%
    1 Month
    +0.93%
    +0.93%
    3 Month
    -10.72%
    -10.72%
    6 Month
    -16.31%
    -16.31%
    1 Year
    -14.43%
    -14.43%

    More News

    Read More
    Why Is Jazz Pharmaceuticals Stock Trading Lower On Thursday?
    Via Benzinga
    Jazz Dives — And Takes Praxis With It — On Essential Tremor Drug Failure
    Via Investor's Business Daily
    3 Blue-Chip Stocks to Triple Your Wealth by 2026: June Edition
    Via InvestorPlace
    Decoding 12 Analyst Evaluations For Jazz Pharmaceuticals
    Via Benzinga
    Demystifying Jazz Pharmaceuticals: Insights From 15 Analyst Reviews
    Via Benzinga
    Breaking Down Jazz Pharmaceuticals: 15 Analysts Share Their Views
    Via Benzinga
    The Analyst Landscape: 12 Takes On Jazz Pharmaceuticals
    Via Benzinga
    This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
    Via Benzinga
    7 Overlooked Stocks Offering Long-Term Stability From the Shadows
    Via InvestorPlace
    3 Cannabis Stocks to Buy Now: May 2024
    Via InvestorPlace
    Topics Cannabis
    Exposures Cannabis
    7 Blue-Chip Stocks to Buy Now: May 2024
    Via InvestorPlace
    Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    3 Cheap Blue-Chip Stocks to Buy Now: May 2024
    Via InvestorPlace
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    7 Cannabis Stocks to Buy for a Smoking-Hot 2024
    Via InvestorPlace
    Topics Cannabis
    Exposures Cannabis
    The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy?
    Via InvestorPlace
    Topics Cannabis
    Exposures Cannabis
    JAZZ Stock Earnings: Jazz Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    3 No-Brainer Stocks to Buy With $300 Right Now
    Via The Motley Fool
    How To Make Your Cannabis Business More Attractive For Investors In 2024: Advice On Financial Health & Innovation
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    HC Wainwright & Co. Maintains Buy Rating for Jazz Pharmaceuticals: Here's What You Need To Know
    Via Benzinga
    7 Biotech Stocks to Buy as Sector Rotation Ramps Up
    Via InvestorPlace
    Time Is Still The Enemy, Says Mom Who Moved Mountains For Her Epileptic Daughter & Still Advocates For Millions Of CBD Users
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.